| Literature DB >> 36238956 |
Yang Lyu1, Tao Han1, Meirong Liu2, Keliang Cui1, Donghao Wang1.
Abstract
Background: To determine whether Pcv-aCO2/Ca-cvO2 combined with Pcv-aCO2 could predict the outcomes in patients complicated with abdominal infection and sepsis after abdominal tumor operation.Entities:
Keywords: Ca-cvO2; Pcv-aCO2; abdominal tumor; hemodynamic; ratio; sepsis
Year: 2022 PMID: 36238956 PMCID: PMC9552675 DOI: 10.2147/TCRM.S374414
Source DB: PubMed Journal: Ther Clin Risk Manag ISSN: 1176-6336 Impact factor: 2.755
Comparison of Primary Tumor of Enrolled Patients
| Improvement | Death / Abandon Treatment | Total | p value | ||
|---|---|---|---|---|---|
| Gender | 0.001 | 0.977 | |||
| Male | 53 | 8 | 61 | ||
| Female | 27 | 4 | 31 | ||
| Primary tumor | 11.223 | 0.047 | |||
| Upper gastrointestinal cancer | 21 | 1 | 22 | ||
| Liver and gallbladder cancer | 9 | 5 | 14 | ||
| Pancreaticoduodenum/bile duct/ periampullary cancer | 20 | 6 | 26 | ||
| Urinary and retroperitoneal cancer | 6 | 0 | 6 | ||
| Colorectal cancer | 21 | 1 | 22 | ||
| Others | 2 | 0 | 2 |
Comparison of Hemodynamic Parameters of Patients Before and After Treatment
| MAP | CVP | ScvO2 (%) | Lactic Acid | Pcv-aCO2 | Ratio | |
|---|---|---|---|---|---|---|
| T0 | 84.65±14.73 | 8.77±5.61 | 63.84±9.19 | 2.15 (1.43, 3.40) | 5.70±2.65 | 1.40±0.59 |
| T3 | 86.80±11.02 | 9.57±4.90 | 67.71±7.35 | 3.16±2.67 | 4.12±2.84 | 1.12±0.84 |
| T6 | 88.73±12.67 | 8.57±4.43 | 69.64±7.76 | 1.70 (1.20, 2.60) | 3.86±1.93 | 1.13±0.55 |
Prediction on Treatment Outcome of Enrolled Patients by T0, T3 and T6 Parameters and SOFA Score
| Parameters | AUC | p value | 95% CI | |
|---|---|---|---|---|
| Lower Limit | Upper Limit | |||
| T0ScvO2 | 0.412 | 0.632 | 0.036 | 0.788 |
| T0 lactic acid | 0.772 | 0.138 | 0.584 | 0.960 |
| T0Ratio | 0.526 | 0.886 | 0.214 | 0.838 |
| T0PcvaCO2 | 0.526 | 0.886 | 0.186 | 0.867 |
| T3ScvO2 | 0.439 | 0.738 | 0.110 | 0.767 |
| T3 lactic acid | 0.825 | 0.077 | 0.644 | 1.000 |
| T3Ratio | 0.754 | 0.165 | 0.561 | 0.948 |
| T3PcvaCO2 | 0.667 | 0.363 | 0.457 | 0.877 |
| T6ScvO2 | 0.289 | 0.251 | 0.000 | 0.636 |
| T6 lactic acid | 0.886 | 0.035 | 0.710 | 1.000 |
| T6Ratio | 0.632 | 0.473 | 0.376 | 0.887 |
| T6PcvaCO2 | 0.579 | 0.667 | 0.353 | 0.805 |
| 6hr LCR | 0.298 | 0.271 | 0.000 | 0.707 |
| T0SOFA | 0.649 | 0.416 | 0.407 | 0.891 |
| T72SOFA | 0.930 | 0.019 | 0.803 | 1.000 |
Abbreviation: LCR, Lactate clearance rate.
Survival Prediction of Patients with Different Indicators by Multivariate Cox Regression Model Analysis
| HR Value | B Value | 95% CI | p value | |
|---|---|---|---|---|
| T0 | ||||
| ScvO2 | 1.007 | 0.007 | 0.976~1.039 | 0.668 |
| Pcv-aCO2 | 0.979 | −0.022 | 0.846~1.132 | 0.771 |
| Ratio | 0.863 | −0.148 | 0.483~1.542 | 0.618 |
| Lactic acid | 0.985 | −0.015 | 0.876~1.108 | 0.804 |
| T3 | ||||
| ScvO2 | 1.020 | 0.019 | 0.949~1.096 | 0.597 |
| Pcv-aCO2 | 1.015 | 0.015 | 0.679~1.518 | 0.941 |
| Ratio | 1.022 | 0.021 | 0.241~4.327 | 0.977 |
| Lactic acid | 0.942 | −0.060 | 0.779~1.138 | 0.534 |
| T6 | ||||
| ScvO2 | 1.026 | 0.026 | 0.985~1.068 | 0.217 |
| Pcv-aCO2 | 1.013 | 0.013 | 0.804~1.276 | 0.913 |
| Ratio | 0.959 | −0.042 | 0.445~2.066 | 0.915 |
| Lactic acid | 0.866 | −0.144 | 0.702~1.069 | 0.180 |
| 6hr LCR | 1.001 | 0.001 | 0.994~1.008 | 0.765 |
| T0SOFA score | 1.045 | 0.044 | 0.954~1.145 | 0.345 |
| T72SOFA score | 0.851 | −0.161 | 0.760~0.953 | 0.005 |
Abbreviations: HR, Hazard Ratio; CI, Confidence Interval.
Figure 1ROC analysis of Pcv-aCO2 and Ratio at T0, T3 and T6 time points based on binary Logistic regression model. AUC of T3 combined prediction probability parameter was the highest (AUC = 0.798, P = 0.005) except for T72 SOFA.
ROC Analysis of Pcv-aCO2 and Ratio at T0, T3 and T6
| Parameters | AUC | p value | 95% CI | |
|---|---|---|---|---|
| LOWER Limit | Upper Limit | |||
| T0Pcv-aCO2+T0Ratio | 0.694 | 0.066 | 0.554 | 0.834 |
| T3Pcv-aCO2+T3Ratio | 0.798 | 0.005 | 0.666 | 0.930 |
| T6Pcv-aCO2+T6Ratio | 0.692 | 0.070 | 0.531 | 0.853 |
| T72SOFA | 0.948 | <0.001 | 0.885 | 1.000 |
Figure 2Kaplan-Meier survival analysis of patients after fluid resuscitation treatment. Patients with higher than combined predictive probability of T3Ratio + T3Pcv-aCO2 had ischemia and hypoxia of tissues and organs after standard fluid resuscitation, and treatment outcome was poor (chi-square value was 8.487, p = 0.014).
Comparison of Treatment Efficacy and Survival of Patients with Different Hemodynamic Parameters
| Pcv-aCO2≤6 mmHg | Pcv-aCO2>6 mmHg | |||
|---|---|---|---|---|
| G1 | G2 | G3 | G4 | |
| Ratio≤1.12 | Ratio>1.12 | Ratio≤1.12 | Ratio>1.12 | |
| T3MAP (mmHg) | 86.84±11.07 | 85.13±11.59 | --- | 89.81±11.06 |
| T3CVP (mmHg) | 8.83±4.29 | 10.40±5.21 | --- | 11.44±6.84 |
| T3ScvO2 (%) | 68.21±7.79 | 68.00±5.77 | --- | 65.22±8.24 |
| T3 | 2.50±2.09 | 5.17±4.03* | --- | 3.48±1.77 |
| 6hr LCR (%) | 15.56 (−18.95, 40.59) | 35.35 (−4.51, 52.64) | --- | 30.52 (11.90, 66.83) |
| T3Pcv-aCO2 (mmHg) | 2.77±1.40 | 4.57±1.06 | --- | 9.37±3.59 |
| T3Ratio | 0.71±0.28 | 1.41±0.22 | --- | 2.55±1.39 |
| T72 SOFA score | 4.00 (2.00, 7.75) | 7.00 (4.00, 14.00)* | --- | 4.00 (2.50, 7.50) |
| Length of ICU admission (d) | 5.00 (3.00, 7.00) | 6.00 (3.00, 10.00) | --- | 5.00 (3.50, 5.00) |
| Outcome (Improvement / death, abandon treatment,%) | 92.7% / 7.3% | 60% / 40%* | --- | 88.9% / 11.1% |
Note: *p < 0.05 for Group 1 vs 2.